As the geopolitical landscape continues to evolve, radiopharmaceutical supply chains are being directly impacted by shifting trade policies, regional instability, infrastructure constraints, and tightening regulatory environments. From isotope export limitations and reliance on concentrated production hubs, to disrupted transport routes and increasing cross-border complexity, these external pressures are actively shaping how and where companies can manufacture, move, and deliver their therapies.

At the same time, organizations are under growing pressure to reduce costs, expand into new markets, and design globally scalable operating models to support latestage trials and commercialization. Thus, the topics of: where to locate manufacturing capacity, how to structure international supply networks, and how to leverage strategic partnerships to overcome regional barriers and unlock access – are becoming increasingly vital for success.

Join this workshop to:

• Evaluate the current geopolitical landscape and its impact on isotope supply, transport routes, and cross-border operations, and benchmarking where your program is most exposed
• Gain strategic insights into how companies are assessing where to locate manufacturing sites and clinical trials
• Understanding the value and how to leverage global partnerships in order to improve supply flexibility, accelerate design timelines, and broaden market access